|Bid||55.20 x 0|
|Ask||55.21 x 0|
|Day's Range||54.08 - 55.73|
|52 Week Range||31.81 - 76.68|
|Beta (3Y Monthly)||5.28|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jun 21, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||76.00|
Canopy Growth's brands, technology and know-how is anticipated to provide Acreage with a significant advantage in an increasingly competitive U.S. market and fuel Acreage's growth. Acreage shareholders will benefit from Acreage's ability to achieve its growth strategy with an anticipated reduced cost of capital based on Canopy Growth affiliation. Canopy Growth shareholders will benefit from accelerated and turnkey access to the U.S. cannabis market upon the closing of the Transaction.
Shares of CBD company CV Sciences jumped 10% on a deal with retailer Kroger to sell its oils in nearly 1,000 stores.
Here's what I would be focused on as marijuana king Canopy Growth Corp (TSX:WEED)(NYSE:CGC) reports earnings next week.
Canopy Growth Corp (TSX:WEED)(NYSE:CGC) and these two other pot stocks will benefit significantly once the U.S. passes legislation that will permit cannabis federally.
Operating results for the largest pot stock in the world are due out next week -- here's what you need to know.
Bluemercury co-founder Barry Beck says the company will be exploring CBD-infused products “in the next 24 months” as the cannabis beauty industry continues to boom.
Canopy Growth Corp (TSX:WEED)(NYSE:CGC) releases its Q4 earnings later this month and investors are hoping a good result can help generate some excitement around the stock.
Here's why Aurora Cannabis (TSX:ACB) (NYSE:ACB) is prepared to deal with a supply glut in the Canadian marijuana market.
If you have doubts that cannabis is on its way from illegal to industrial, take a look inside Cresco Labs’ custom built, 43-thousand square-foot production facility in Joliet, Illinois.
At first glance, cannabis and cryptocurrencies seem to have a lot in common. Both comprise highly speculative markets subject to exuberant highs and crushing lows. The legality and regulation of each has languished in the gray. And to many mainstream investors, both have failed to shake synonymy with the black market.
Marijuana stocks got clobbered last month, and their performances are a mixed bag so far in June.
SMITHS FALLS, ON , June 7, 2019 /CNW/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NYSE: CGC) will release its financial results for the fourth quarter ...
With cannabis stocks getting lower and lower, now is the time to buy up Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) before it soars yet again.
A $10,000 investment made in Canopy Growth Corp (TSX:WEED)(NYSE:CGC) back in June 2014 would have made an investor pretty wealthy.
Healthcare stocks like Canopy Growth Corp. (TSX:WEED) (NYSE:CGC) and Northwest Healthcare Properties REIT (TSX:NWH.UN) are two very different but equally valuable stocks for exposure to the very lucrative healthcare sector.
The nascent marijuana industry has made significant strides over the past several years. But the once-illicit marijuana market still has hurdles to cross before unlocking its full potential, according to executives at some of the world’s leading cannabis companies.
In 5 years’ time, Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) would probably be the undisputed leader in the cannabis industry. Buying signals are strong as all signs are pointing in that direction.
While vital to the long-term success of the cannabis industry, don't overestimate the near-term impact of pushing into overseas markets.